Clinical trial Recruiting at 1 site Observational Ages 65 and up

Investigating proteins related to postoperative delirium in diabetes patients

Official title: Predictive Effect of TGF-β Combined With INS-PI3K-AKT Signaling Pathway Related Proteins (ADNP, MAP6, Pgc-1α) for POD in Diabetes Patients

Run by Zhejiang Cancer Hospital · NCT06426953 · Data updated 2026-11-12

This study is trying to see if certain proteins in the blood are linked to confusion after surgery in people with diabetes.

More Diabetes trials

Quick facts

Study typeObservational
Ages65 Years and up
SexAll
Enrollment180 (estimated)
SponsorZhejiang Cancer Hospital
Academic / other
Locations2 sites (Duyun, Guizhou and 1 other locations)
StatusRecruiting
StartedMay 20, 2024
Main results expectedDecember 30, 2025
Study endsAugust 30, 2026
Registry record updatedSeptember 29, 2025
Trial IDNCT06426953 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are elderly patients aged 65 and older with a history of diabetes for at least two years.

Probably not a fit

Patients with severe neurological or psychiatric conditions, or those with significant cardiac or renal dysfunction, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the relationship between postoperative delirium (POD) and specific proteins associated with the TGF-β and INS-PI3K-AKT signaling pathways in patients with diabetes. Conducted at two centers, the study involves collecting blood samples from participants before surgery to analyze levels of proteins such as ADNP, MAP6, and PGC-1α using ELISA. The study is designed to be single-blind, meaning that subjects and evaluators are unaware of the specific details of the study to minimize bias.

Why it matters

Potential benefit: If successful, this study could lead to better predictive markers for postoperative delirium in diabetic patients, potentially improving patient outcomes.

How similar studies have gone: While this study explores a specific relationship, similar studies have shown promise in identifying biomarkers for postoperative complications, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥65 years
2. History of diabetes ≥2 years and Glycated hemoglobin ≥6.5% or no history of diabetes and normal blood glucose
3. The ASA rating is Class I to III
4. The elderly patients of limited thoracic and abdominal tumor surgery

Exclusion Criteria:

1. Refused to participate
2. Previous history of schizophrenia, epilepsy, Parkinson's disease
3. History of alcohol abuse or drug dependence
4. Patients with ASA grade IV and above
5. Severe visual or hearing impairment, can not cooperate with the completion of cognitive function tests
6. Participants in other clinical trials within the last two months
7. Patients with severe arrhythmia or cardiac dysfunction(EF\<40%)
8. There was a clear history of neurological and psychiatric problems or long-term use of sedatives or antidepressants
9. History of cerebrovascular disease or brain surgery or trauma
10. Severe liver dysfunction (Child-Pugh class C) or severe renal dysfunction (requiring dialysis)

Where it's running

  • Zhejiang Cancer Hospital
    Hangzhou, Zhejiang, China
    Recruiting
  • The People's hospital of Qiannan
    Duyun, Guizhou, China
    Not yet recruiting

Study contacts

  • Principal investigator: Kangjie Xie, MD — Zhejiang Cancer Hospital
  • Study coordinator: Kangjie Xie, MD
  • Email: xiekj@zjcc.org.cn
  • Phone: 8613516721870

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.